Share Price and Basic Stock Data
Last Updated: October 14, 2025, 6:49 am
| PEG Ratio | -8.74 |
|---|
Analyst Insight & Comprehensive Analysis
Business Overview and Revenue Trends
Fairchem Organics Ltd operates in the chemicals sector, focusing on organic chemicals. The company reported a market capitalization of ₹1,003 Cr and a share price of ₹771. Revenue trends indicate fluctuations, with sales recorded at ₹225.12 Cr in June 2022, dipping to ₹102.48 Cr by December 2022, and a slight recovery to ₹160.59 Cr in June 2023. By September 2023, sales stood at ₹152.21 Cr, showcasing a consistent decline in the latter part of the fiscal year, ultimately leading to ₹538 Cr in total sales for FY 2025. Operating profit margins (OPM) have also shown volatility, with a high of 17.80% in June 2022, declining to 3.99% by FY 2025. This trend reflects challenges in maintaining profitability amidst fluctuating sales. The company’s performance is further impacted by rising expenses, which were ₹185.05 Cr in June 2022 and decreased to ₹495 Cr in FY 2025. The overall revenue trajectory indicates that while Fairchem has potential, it faces significant headwinds that could affect its future growth.
Profitability and Efficiency Metrics
Fairchem Organics’ profitability has been inconsistent, as evident from its operating profit, which declined from ₹40.07 Cr in June 2022 to ₹5.23 Cr in June 2025. The company’s net profit mirrored this trend, with reported figures of ₹27.03 Cr in June 2022, dropping to ₹1.17 Cr by June 2025. Notably, the net profit margin fell from 12% in March 2023 to merely 3.99% in FY 2025, indicating a struggle to convert sales into profit effectively. The return on equity (ROE) stood at 7.51%, while the return on capital employed (ROCE) was reported at 10.2%, both of which are relatively low for the industry, suggesting that the company is not utilizing its equity and capital efficiently. The interest coverage ratio (ICR) was reported at a robust 16.07x, indicating that Fairchem can comfortably meet its interest obligations, but the declining profitability might pose future challenges in sustaining this level of coverage.
Balance Sheet Strength and Financial Ratios
Fairchem’s balance sheet reflects a mix of strengths and vulnerabilities. The company reported reserves of ₹289 Cr against borrowings of ₹63 Cr, indicating a solid equity base relative to its debt. This results in a low total debt-to-equity ratio of 0.02, which is favorable compared to typical industry benchmarks. The current ratio of 5.10 suggests strong liquidity, indicating that Fairchem can meet its short-term liabilities effectively. However, the cash conversion cycle (CCC) has extended significantly from 89 days in FY 2023 to 137 days in FY 2025, which raises concerns about the efficiency of working capital management. The price-to-book value ratio stood at 5.33x, which is relatively high, indicating that the stock might be overvalued compared to its book value. The company’s ability to maintain its financial health amidst decreasing profitability and increasing cash conversion cycles will be crucial for its future stability.
Shareholding Pattern and Investor Confidence
The shareholding pattern of Fairchem Organics reflects a stable promoter holding of 61.20%, which has shown a slight increase over time, suggesting confidence from the management. Foreign institutional investors (FIIs) hold 6.28%, while domestic institutional investors (DIIs) account for 5.77%, indicating moderate institutional interest. The public shareholding stands at 26.76%, with the total number of shareholders reported at 29,051, reflecting a diversified ownership structure. However, the decline in public shareholding from 29.45% in September 2022 to 26.76% in June 2025 may raise concerns about investor sentiment. The gradual decrease in public participation could be a sign of waning confidence, particularly in light of the declining profitability metrics. Thus, while promoter confidence remains strong, the trends in institutional and public holdings could impact market perception and future capital raising efforts.
Outlook, Risks, and Final Insight
If margins sustain at current levels, Fairchem Organics may face challenges in maintaining investor confidence and operational efficiency. The decline in profitability metrics, coupled with an increasing cash conversion cycle, suggests potential liquidity issues in the future. Additionally, external factors such as fluctuations in raw material costs and market demand for organic chemicals could further strain the company’s financial health. However, if the management can implement effective cost-control measures and enhance operational efficiencies, there is a possibility of stabilizing profits and improving margins. The robust interest coverage ratio indicates that the company can manage its debt effectively, which could support future growth strategies. Nonetheless, Fairchem must address its declining sales trends and operational inefficiencies to leverage its strengths and mitigate risks effectively. Overall, navigating these challenges will be critical for Fairchem’s long-term viability in the competitive chemicals sector.
Source: Getaka Fundamental Analysis | Generated using proprietary financial data.
Competitors of Fairchem Organics Ltd
| Stock Name ⇩ | Market Cap ⇩ | Current Price ⇩ | High / Low ⇩ | Stock P/E ⇩ | Book Value ⇩ | Dividend Yield ⇩ | ROCE ⇩ | ROE ⇩ | Face Value ⇩ |
|---|---|---|---|---|---|---|---|---|---|
| Gujchem Distillers India Ltd | 107 Cr. | 300 | 530/255 | 110 | 390 | 0.03 % | 0.21 % | 0.09 % | 1.00 |
| Elantas Beck India Ltd | 7,611 Cr. | 9,600 | 14,740/8,150 | 57.2 | 1,177 | 0.08 % | 23.0 % | 17.4 % | 10.0 |
| Crestchem Ltd | 39.6 Cr. | 132 | 329/114 | 16.0 | 24.9 | 0.76 % | 59.9 % | 44.1 % | 10.0 |
| Chemiesynth (Vapi) Ltd | 11.0 Cr. | 35.8 | 35.8/35.8 | 35.8 | 0.00 % | 3.10 % | 0.99 % | 10.0 | |
| Archit Organosys Ltd | 93.8 Cr. | 45.7 | 51.4/34.2 | 15.4 | 33.7 | 1.09 % | 10.8 % | 7.62 % | 10.0 |
| Industry Average | 4,765.00 Cr | 1,739.05 | 431.86 | 340.62 | 0.38% | 14.38% | 10.33% | 7.41 |
Quarterly Result
| Metric | Jun 2022 | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 225.12 | 168.54 | 102.48 | 151.90 | 160.59 | 152.21 | 148.11 | 160.56 | 164.93 | 138.62 | 113.57 | 120.78 | 131.06 |
| Expenses | 185.05 | 159.22 | 98.81 | 132.66 | 148.96 | 135.38 | 128.36 | 141.79 | 143.16 | 129.86 | 105.74 | 116.36 | 125.83 |
| Operating Profit | 40.07 | 9.32 | 3.67 | 19.24 | 11.63 | 16.83 | 19.75 | 18.77 | 21.77 | 8.76 | 7.83 | 4.42 | 5.23 |
| OPM % | 17.80% | 5.53% | 3.58% | 12.67% | 7.24% | 11.06% | 13.33% | 11.69% | 13.20% | 6.32% | 6.89% | 3.66% | 3.99% |
| Other Income | 0.28 | 0.00 | 0.27 | 0.17 | 0.15 | 0.46 | 0.25 | 0.28 | 0.24 | 0.38 | 0.48 | 0.24 | 0.13 |
| Interest | 2.41 | 1.62 | 0.92 | 1.32 | 1.35 | 1.30 | 0.97 | 0.62 | 0.81 | 1.02 | 0.93 | 0.91 | 1.01 |
| Depreciation | 1.89 | 2.05 | 2.09 | 2.13 | 2.15 | 2.18 | 2.40 | 2.55 | 2.59 | 2.64 | 2.67 | 2.64 | 2.74 |
| Profit before tax | 36.05 | 5.65 | 0.93 | 15.96 | 8.28 | 13.81 | 16.63 | 15.88 | 18.61 | 5.48 | 4.71 | 1.11 | 1.61 |
| Tax % | 25.02% | 29.20% | 35.48% | 25.69% | 25.97% | 25.56% | 25.86% | 25.88% | 25.63% | 26.82% | 25.48% | 46.85% | 27.33% |
| Net Profit | 27.03 | 4.00 | 0.61 | 11.86 | 6.12 | 10.29 | 12.33 | 11.76 | 13.85 | 4.01 | 3.52 | 0.59 | 1.17 |
| EPS in Rs | 20.76 | 3.07 | 0.47 | 9.11 | 4.70 | 7.90 | 9.47 | 9.03 | 10.64 | 3.08 | 2.70 | 0.45 | 0.90 |
Last Updated: August 20, 2025, 11:00 am
Below is a detailed analysis of the quarterly data for Fairchem Organics Ltd based on the most recent figures (Jun 2025) and their trends compared to the previous period:
- For Sales, as of Jun 2025, the value is 131.06 Cr.. The value appears strong and on an upward trend. It has increased from 120.78 Cr. (Mar 2025) to 131.06 Cr., marking an increase of 10.28 Cr..
- For Expenses, as of Jun 2025, the value is 125.83 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 116.36 Cr. (Mar 2025) to 125.83 Cr., marking an increase of 9.47 Cr..
- For Operating Profit, as of Jun 2025, the value is 5.23 Cr.. The value appears strong and on an upward trend. It has increased from 4.42 Cr. (Mar 2025) to 5.23 Cr., marking an increase of 0.81 Cr..
- For OPM %, as of Jun 2025, the value is 3.99%. The value appears strong and on an upward trend. It has increased from 3.66% (Mar 2025) to 3.99%, marking an increase of 0.33%.
- For Other Income, as of Jun 2025, the value is 0.13 Cr.. The value appears to be declining and may need further review. It has decreased from 0.24 Cr. (Mar 2025) to 0.13 Cr., marking a decrease of 0.11 Cr..
- For Interest, as of Jun 2025, the value is 1.01 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 0.91 Cr. (Mar 2025) to 1.01 Cr., marking an increase of 0.10 Cr..
- For Depreciation, as of Jun 2025, the value is 2.74 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 2.64 Cr. (Mar 2025) to 2.74 Cr., marking an increase of 0.10 Cr..
- For Profit before tax, as of Jun 2025, the value is 1.61 Cr.. The value appears strong and on an upward trend. It has increased from 1.11 Cr. (Mar 2025) to 1.61 Cr., marking an increase of 0.50 Cr..
- For Tax %, as of Jun 2025, the value is 27.33%. The value appears to be improving (decreasing) as expected. It has decreased from 46.85% (Mar 2025) to 27.33%, marking a decrease of 19.52%.
- For Net Profit, as of Jun 2025, the value is 1.17 Cr.. The value appears strong and on an upward trend. It has increased from 0.59 Cr. (Mar 2025) to 1.17 Cr., marking an increase of 0.58 Cr..
- For EPS in Rs, as of Jun 2025, the value is 0.90. The value appears strong and on an upward trend. It has increased from 0.45 (Mar 2025) to 0.90, marking an increase of 0.45.
Overall, while many items appear to show a positive trend, any significant downward movement warrant further investigation.
Profit & Loss - Annual Report
Last Updated: July 22, 2025, 3:52 pm
| Metric | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|---|
| Sales | 306 | 397 | 643 | 648 | 621 | 538 |
| Expenses | 258 | 328 | 538 | 576 | 554 | 495 |
| Operating Profit | 49 | 69 | 105 | 72 | 67 | 43 |
| OPM % | 16% | 17% | 16% | 11% | 11% | 8% |
| Other Income | 6 | 0 | 0 | 1 | 1 | 1 |
| Interest | 7 | 7 | 7 | 6 | 4 | 4 |
| Depreciation | 6 | 7 | 7 | 8 | 9 | 11 |
| Profit before tax | 42 | 56 | 91 | 59 | 55 | 30 |
| Tax % | 18% | 24% | 26% | 26% | 26% | 27% |
| Net Profit | 35 | 42 | 68 | 44 | 40 | 22 |
| EPS in Rs | 32.62 | 52.15 | 33.41 | 31.10 | 16.87 | |
| Dividend Payout % | 0% | 11% | 25% | 22% | 24% | 44% |
YoY Net Profit Growth
| Year | 2020-2021 | 2021-2022 | 2022-2023 | 2023-2024 | 2024-2025 |
|---|---|---|---|---|---|
| YoY Net Profit Growth (%) | 20.00% | 61.90% | -35.29% | -9.09% | -45.00% |
| Change in YoY Net Profit Growth (%) | 0.00% | 41.90% | -97.20% | 26.20% | -35.91% |
Fairchem Organics Ltd has shown an inconsistent trend in YoY Net Profit Growth (%) in the last 5 years from 2020-2021 to 2024-2025.
Growth
| Compounded Sales Growth | |
|---|---|
| 10 Years: | % |
| 5 Years: | 12% |
| 3 Years: | -6% |
| TTM: | -19% |
| Compounded Profit Growth | |
|---|---|
| 10 Years: | % |
| 5 Years: | -9% |
| 3 Years: | -31% |
| TTM: | -81% |
| Stock Price CAGR | |
|---|---|
| 10 Years: | % |
| 5 Years: | % |
| 3 Years: | -26% |
| 1 Year: | -38% |
| Return on Equity | |
|---|---|
| 10 Years: | % |
| 5 Years: | 19% |
| 3 Years: | 13% |
| Last Year: | 8% |
Last Updated: September 5, 2025, 3:50 am
Balance Sheet
Last Updated: October 10, 2025, 2:00 pm
| Month | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|---|
| Equity Capital | 0.00 | 13 | 13 | 13 | 13 | 13 |
| Reserves | 127 | 156 | 219 | 246 | 277 | 289 |
| Borrowings | 67 | 57 | 62 | 50 | 7 | 63 |
| Other Liabilities | 25 | 33 | 30 | 33 | 37 | 37 |
| Total Liabilities | 219 | 259 | 324 | 342 | 334 | 402 |
| Fixed Assets | 126 | 126 | 141 | 156 | 191 | 201 |
| CWIP | 9 | 29 | 42 | 35 | 6 | 12 |
| Investments | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Assets | 83 | 103 | 141 | 151 | 137 | 189 |
| Total Assets | 219 | 259 | 324 | 342 | 334 | 402 |
Below is a detailed analysis of the balance sheet data for Fairchem Organics Ltd based on the most recent figures (Mar 2025) and their trends compared to the previous period:
- For Equity Capital, as of Mar 2025, the value is 13.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2024) which recorded 13.00 Cr..
- For Reserves, as of Mar 2025, the value is 289.00 Cr.. The value appears strong and on an upward trend. It has increased from 277.00 Cr. (Mar 2024) to 289.00 Cr., marking an increase of 12.00 Cr..
- For Borrowings, as of Mar 2025, the value is 63.00 Cr.. The value appears to be increasing, which may not be favorable. Additionally, since Reserves exceed Borrowings, this is considered a positive sign. It has increased from 7.00 Cr. (Mar 2024) to 63.00 Cr., marking an increase of 56.00 Cr..
- For Other Liabilities, as of Mar 2025, the value is 37.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2024) which recorded 37.00 Cr..
- For Total Liabilities, as of Mar 2025, the value is 402.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 334.00 Cr. (Mar 2024) to 402.00 Cr., marking an increase of 68.00 Cr..
- For Fixed Assets, as of Mar 2025, the value is 201.00 Cr.. The value appears strong and on an upward trend. It has increased from 191.00 Cr. (Mar 2024) to 201.00 Cr., marking an increase of 10.00 Cr..
- For CWIP, as of Mar 2025, the value is 12.00 Cr.. The value appears strong and on an upward trend. It has increased from 6.00 Cr. (Mar 2024) to 12.00 Cr., marking an increase of 6.00 Cr..
- For Investments, as of Mar 2025, the value is 0.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2024) which recorded 0.00 Cr..
- For Other Assets, as of Mar 2025, the value is 189.00 Cr.. The value appears strong and on an upward trend. It has increased from 137.00 Cr. (Mar 2024) to 189.00 Cr., marking an increase of 52.00 Cr..
- For Total Assets, as of Mar 2025, the value is 402.00 Cr.. The value appears strong and on an upward trend. It has increased from 334.00 Cr. (Mar 2024) to 402.00 Cr., marking an increase of 68.00 Cr..
Notably, the Reserves (289.00 Cr.) exceed the Borrowings (63.00 Cr.), indicating a solid financial buffer.
Overall, while many items appear to show a positive trend, any significant downward movement or items where Borrowings exceed Reserves warrant further investigation.
Cash Flow - No data available for this post.
Free Cash Flow
| Month | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|---|
| Free Cash Flow | -18.00 | 12.00 | 43.00 | 22.00 | 60.00 | -20.00 |
Free Cash Flow = Income Generated from Operational Activities - Borrowings - Capital Work in Progress (CWIP)
Consistent positive free cash flow is crucial for businesses as it indicates their ability to generate cash from their core operations. It provides financial flexibility, allowing companies to invest in growth opportunities, pay dividends to shareholders, reduce debt, and weather economic downturns more effectively.
Financial Efficiency Indicators
| Month | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|---|
| Debtor Days | 45 | 43 | 35 | 35 | 33 | 58 |
| Inventory Days | 65 | 64 | 57 | 61 | 57 | 87 |
| Days Payable | 12 | 15 | 7 | 8 | 11 | 8 |
| Cash Conversion Cycle | 98 | 91 | 85 | 89 | 80 | 137 |
| Working Capital Days | 14 | 43 | 40 | 46 | 63 | 68 |
| ROCE % | 30% | 38% | 22% | 19% | 10% |
This stock is not held by any mutual fund.
Key Financial Ratios
| Month | Mar 24 | Mar 23 | Mar 22 | Mar 21 | Mar 20 |
|---|---|---|---|---|---|
| FaceValue | 10.00 | 10.00 | 10.00 | 10.00 | 10.00 |
| Basic EPS (Rs.) | 31.10 | 33.41 | 52.15 | 32.63 | 26.65 |
| Diluted EPS (Rs.) | 31.10 | 33.41 | 52.15 | 32.63 | 26.65 |
| Cash EPS (Rs.) | 38.23 | 39.67 | 57.63 | 37.68 | 0.00 |
| Book Value[Excl.RevalReserv]/Share (Rs.) | 222.67 | 199.11 | 178.29 | 129.59 | 0.00 |
| Book Value[Incl.RevalReserv]/Share (Rs.) | 222.67 | 199.11 | 178.29 | 129.59 | 0.00 |
| Dividend / Share (Rs.) | 7.50 | 7.50 | 13.00 | 3.50 | 0.00 |
| Revenue From Operations / Share (Rs.) | 477.29 | 497.69 | 493.96 | 304.56 | 0.00 |
| PBDIT / Share (Rs.) | 52.31 | 56.07 | 80.81 | 52.96 | 0.00 |
| PBIT / Share (Rs.) | 45.19 | 49.81 | 75.34 | 47.91 | 0.00 |
| PBT / Share (Rs.) | 41.93 | 45.00 | 70.07 | 42.67 | 0.00 |
| Net Profit / Share (Rs.) | 31.10 | 33.41 | 52.15 | 32.63 | 0.00 |
| PBDIT Margin (%) | 10.96 | 11.26 | 16.36 | 17.38 | 17.93 |
| PBIT Margin (%) | 9.46 | 10.00 | 15.25 | 15.73 | 15.98 |
| PBT Margin (%) | 8.78 | 9.04 | 14.18 | 14.01 | 13.83 |
| Net Profit Margin (%) | 6.51 | 6.71 | 10.55 | 10.71 | 11.32 |
| Return on Networth / Equity (%) | 13.96 | 16.77 | 29.25 | 25.17 | 30.52 |
| Return on Capital Employeed (%) | 19.08 | 23.52 | 38.21 | 30.01 | 31.44 |
| Return On Assets (%) | 12.11 | 12.70 | 20.95 | 16.42 | 15.85 |
| Long Term Debt / Equity (X) | 0.00 | 0.00 | 0.04 | 0.15 | 0.14 |
| Total Debt / Equity (X) | 0.02 | 0.19 | 0.26 | 0.28 | 0.53 |
| Asset Turnover Ratio (%) | 1.84 | 1.94 | 2.21 | 1.66 | 0.00 |
| Current Ratio (X) | 5.10 | 2.22 | 2.04 | 1.93 | 1.19 |
| Quick Ratio (X) | 2.42 | 1.03 | 0.99 | 1.04 | 0.62 |
| Inventory Turnover Ratio (X) | 6.12 | 6.69 | 8.17 | 6.89 | 0.00 |
| Dividend Payout Ratio (NP) (%) | 24.11 | 38.91 | 6.71 | 0.00 | 30.22 |
| Dividend Payout Ratio (CP) (%) | 19.61 | 32.77 | 6.07 | 0.00 | 25.79 |
| Earning Retention Ratio (%) | 75.89 | 61.09 | 93.29 | 0.00 | 69.78 |
| Cash Earning Retention Ratio (%) | 80.39 | 67.23 | 93.93 | 0.00 | 74.21 |
| Interest Coverage Ratio (X) | 16.07 | 11.66 | 15.35 | 10.11 | 8.35 |
| Interest Coverage Ratio (Post Tax) (X) | 10.55 | 7.95 | 10.91 | 7.23 | 6.27 |
| Enterprise Value (Cr.) | 1552.81 | 1240.34 | 2021.19 | 1022.58 | 0.00 |
| EV / Net Operating Revenue (X) | 2.50 | 1.91 | 3.14 | 2.58 | 0.00 |
| EV / EBITDA (X) | 22.80 | 16.99 | 19.21 | 14.83 | 0.00 |
| MarketCap / Net Operating Revenue (X) | 2.49 | 1.84 | 3.05 | 2.46 | 0.00 |
| Retention Ratios (%) | 75.88 | 61.08 | 93.28 | 0.00 | 69.77 |
| Price / BV (X) | 5.33 | 4.59 | 8.44 | 5.78 | 0.00 |
| Price / Net Operating Revenue (X) | 2.49 | 1.84 | 3.05 | 2.46 | 0.00 |
| EarningsYield | 0.02 | 0.03 | 0.03 | 0.04 | 0.00 |
After reviewing the key financial ratios for Fairchem Organics Ltd, here is a detailed analysis based on the latest available data and recent trends:
- For FaceValue, as of Mar 24, the value is 10.00. This value is within the healthy range. There is no change compared to the previous period (Mar 23) which recorded 10.00.
- For Basic EPS (Rs.), as of Mar 24, the value is 31.10. This value is within the healthy range. It has decreased from 33.41 (Mar 23) to 31.10, marking a decrease of 2.31.
- For Diluted EPS (Rs.), as of Mar 24, the value is 31.10. This value is within the healthy range. It has decreased from 33.41 (Mar 23) to 31.10, marking a decrease of 2.31.
- For Cash EPS (Rs.), as of Mar 24, the value is 38.23. This value is within the healthy range. It has decreased from 39.67 (Mar 23) to 38.23, marking a decrease of 1.44.
- For Book Value[Excl.RevalReserv]/Share (Rs.), as of Mar 24, the value is 222.67. It has increased from 199.11 (Mar 23) to 222.67, marking an increase of 23.56.
- For Book Value[Incl.RevalReserv]/Share (Rs.), as of Mar 24, the value is 222.67. It has increased from 199.11 (Mar 23) to 222.67, marking an increase of 23.56.
- For Dividend / Share (Rs.), as of Mar 24, the value is 7.50. This value exceeds the healthy maximum of 3. There is no change compared to the previous period (Mar 23) which recorded 7.50.
- For Revenue From Operations / Share (Rs.), as of Mar 24, the value is 477.29. It has decreased from 497.69 (Mar 23) to 477.29, marking a decrease of 20.40.
- For PBDIT / Share (Rs.), as of Mar 24, the value is 52.31. This value is within the healthy range. It has decreased from 56.07 (Mar 23) to 52.31, marking a decrease of 3.76.
- For PBIT / Share (Rs.), as of Mar 24, the value is 45.19. This value is within the healthy range. It has decreased from 49.81 (Mar 23) to 45.19, marking a decrease of 4.62.
- For PBT / Share (Rs.), as of Mar 24, the value is 41.93. This value is within the healthy range. It has decreased from 45.00 (Mar 23) to 41.93, marking a decrease of 3.07.
- For Net Profit / Share (Rs.), as of Mar 24, the value is 31.10. This value is within the healthy range. It has decreased from 33.41 (Mar 23) to 31.10, marking a decrease of 2.31.
- For PBDIT Margin (%), as of Mar 24, the value is 10.96. This value is within the healthy range. It has decreased from 11.26 (Mar 23) to 10.96, marking a decrease of 0.30.
- For PBIT Margin (%), as of Mar 24, the value is 9.46. This value is below the healthy minimum of 10. It has decreased from 10.00 (Mar 23) to 9.46, marking a decrease of 0.54.
- For PBT Margin (%), as of Mar 24, the value is 8.78. This value is below the healthy minimum of 10. It has decreased from 9.04 (Mar 23) to 8.78, marking a decrease of 0.26.
- For Net Profit Margin (%), as of Mar 24, the value is 6.51. This value is within the healthy range. It has decreased from 6.71 (Mar 23) to 6.51, marking a decrease of 0.20.
- For Return on Networth / Equity (%), as of Mar 24, the value is 13.96. This value is below the healthy minimum of 15. It has decreased from 16.77 (Mar 23) to 13.96, marking a decrease of 2.81.
- For Return on Capital Employeed (%), as of Mar 24, the value is 19.08. This value is within the healthy range. It has decreased from 23.52 (Mar 23) to 19.08, marking a decrease of 4.44.
- For Return On Assets (%), as of Mar 24, the value is 12.11. This value is within the healthy range. It has decreased from 12.70 (Mar 23) to 12.11, marking a decrease of 0.59.
- For Long Term Debt / Equity (X), as of Mar 24, the value is 0.00. This value is below the healthy minimum of 0.2. There is no change compared to the previous period (Mar 23) which recorded 0.00.
- For Total Debt / Equity (X), as of Mar 24, the value is 0.02. This value is within the healthy range. It has decreased from 0.19 (Mar 23) to 0.02, marking a decrease of 0.17.
- For Asset Turnover Ratio (%), as of Mar 24, the value is 1.84. It has decreased from 1.94 (Mar 23) to 1.84, marking a decrease of 0.10.
- For Current Ratio (X), as of Mar 24, the value is 5.10. This value exceeds the healthy maximum of 3. It has increased from 2.22 (Mar 23) to 5.10, marking an increase of 2.88.
- For Quick Ratio (X), as of Mar 24, the value is 2.42. This value exceeds the healthy maximum of 2. It has increased from 1.03 (Mar 23) to 2.42, marking an increase of 1.39.
- For Inventory Turnover Ratio (X), as of Mar 24, the value is 6.12. This value is within the healthy range. It has decreased from 6.69 (Mar 23) to 6.12, marking a decrease of 0.57.
- For Dividend Payout Ratio (NP) (%), as of Mar 24, the value is 24.11. This value is within the healthy range. It has decreased from 38.91 (Mar 23) to 24.11, marking a decrease of 14.80.
- For Dividend Payout Ratio (CP) (%), as of Mar 24, the value is 19.61. This value is below the healthy minimum of 20. It has decreased from 32.77 (Mar 23) to 19.61, marking a decrease of 13.16.
- For Earning Retention Ratio (%), as of Mar 24, the value is 75.89. This value exceeds the healthy maximum of 70. It has increased from 61.09 (Mar 23) to 75.89, marking an increase of 14.80.
- For Cash Earning Retention Ratio (%), as of Mar 24, the value is 80.39. This value exceeds the healthy maximum of 70. It has increased from 67.23 (Mar 23) to 80.39, marking an increase of 13.16.
- For Interest Coverage Ratio (X), as of Mar 24, the value is 16.07. This value is within the healthy range. It has increased from 11.66 (Mar 23) to 16.07, marking an increase of 4.41.
- For Interest Coverage Ratio (Post Tax) (X), as of Mar 24, the value is 10.55. This value is within the healthy range. It has increased from 7.95 (Mar 23) to 10.55, marking an increase of 2.60.
- For Enterprise Value (Cr.), as of Mar 24, the value is 1,552.81. It has increased from 1,240.34 (Mar 23) to 1,552.81, marking an increase of 312.47.
- For EV / Net Operating Revenue (X), as of Mar 24, the value is 2.50. This value is within the healthy range. It has increased from 1.91 (Mar 23) to 2.50, marking an increase of 0.59.
- For EV / EBITDA (X), as of Mar 24, the value is 22.80. This value exceeds the healthy maximum of 15. It has increased from 16.99 (Mar 23) to 22.80, marking an increase of 5.81.
- For MarketCap / Net Operating Revenue (X), as of Mar 24, the value is 2.49. This value is within the healthy range. It has increased from 1.84 (Mar 23) to 2.49, marking an increase of 0.65.
- For Retention Ratios (%), as of Mar 24, the value is 75.88. This value exceeds the healthy maximum of 70. It has increased from 61.08 (Mar 23) to 75.88, marking an increase of 14.80.
- For Price / BV (X), as of Mar 24, the value is 5.33. This value exceeds the healthy maximum of 3. It has increased from 4.59 (Mar 23) to 5.33, marking an increase of 0.74.
- For Price / Net Operating Revenue (X), as of Mar 24, the value is 2.49. This value is within the healthy range. It has increased from 1.84 (Mar 23) to 2.49, marking an increase of 0.65.
- For EarningsYield, as of Mar 24, the value is 0.02. This value is below the healthy minimum of 5. It has decreased from 0.03 (Mar 23) to 0.02, marking a decrease of 0.01.
Overall, while many metrics show healthy performance, any figures highlighted in red or significant downward trends warrant further investigation.
Strength and Weakness
| Strength | Weakness |
|---|---|
|
|
Stock Analysis
- Considering all of the following key financial indicators, prospective investors are encouraged to conduct thorough research and seek professional guidance before considering any investment in Fairchem Organics Ltd:
- Net Profit Margin: 6.51%
- Net Profit Margin: This metric indicates the percentage of profit a company makes from its total revenue. A higher net profit margin is generally desirable as it reflects better profitability.
- ROCE: 19.08% (Industry Average ROCE: 14.38%)
- ROCE (Return on Capital Employed): ROCE measures a company's profitability and the efficiency with which its capital is employed. A higher ROCE indicates efficient use of capital.
- ROE%: 13.96% (Industry Average ROE: 10.33%)
- ROE (Return on Equity): ROE measures a company's profitability relative to shareholders' equity. A higher ROE indicates efficient use of shareholders' funds.
- Interest Coverage Ratio (Post Tax): 10.55
- Interest Coverage Ratio: The interest coverage ratio measures a company's ability to cover its interest payments on outstanding debt. A ratio greater than 2 is generally considered healthy as it indicates the company can meet its interest obligations comfortably.
- Quick Ratio: 2.42
- Quick Ratio: The quick ratio assesses a company's ability to cover its short-term liabilities with its most liquid assets. A ratio higher than 1 suggests the company can meet its short-term obligations without relying heavily on inventory.
- Stock P/E: 108 (Industry average Stock P/E: 431.86)
- Stock P/E (Price-to-Earnings) Ratio: The P/E ratio compares a company's current share price to its earnings per share. A lower P/E ratio relative to industry peers or historical values may indicate that the stock is undervalued.
- Total Debt / Equity: 0.02
- Total Debt / Equity: This ratio measures a company's financial leverage by comparing its total debt to its total equity. A lower ratio indicates lower financial risk and greater financial stability.
Stock Rating: - Net Profit Margin: 6.51%
About the Company - Qualitative Analysis
| INDUSTRY | ADDRESS | CONTACT |
|---|---|---|
| Chemicals - Organic - Others | 253/P & 312, Village Chekhala, Ahmedabad District Gujarat 382115 | cs@fairchem.in http://www.fairchem.in |
| Management | |
|---|---|
| Name | Position Held |
| Mr. Nahoosh Jariwala | Chairman & Managing Director |
| Mr. Sudhin Choksey | Independent Director |
| Mr. Venkatraman Srinivasan | Independent Director |
| Mr. Darius Pandole | Independent Director |
| Ms. Sonal Ambani | Independent Director |
| Mr. Sumit Maheshwari | Nominee Director |
FAQ
What is the intrinsic value of Fairchem Organics Ltd?
Fairchem Organics Ltd's intrinsic value (as of 14 October 2025) is 1519.97 which is 97.14% higher the current market price of 771.00, indicating undervalued. Calculated using the PE ratio method, this valuation considers the company's ₹1,004 Cr. market cap, FY2025-2026 high/low of 1,308/747, reserves of ₹289 Cr, and liabilities of 402 Cr.
What is the Market Cap of Fairchem Organics Ltd?
The Market Cap of Fairchem Organics Ltd is 1,004 Cr..
What is the current Stock Price of Fairchem Organics Ltd as on 14 October 2025?
The current stock price of Fairchem Organics Ltd as on 14 October 2025 is 771.
What is the High / Low of Fairchem Organics Ltd stocks in FY 2025-2026?
In FY 2025-2026, the High / Low of Fairchem Organics Ltd stocks is 1,308/747.
What is the Stock P/E of Fairchem Organics Ltd?
The Stock P/E of Fairchem Organics Ltd is 108.
What is the Book Value of Fairchem Organics Ltd?
The Book Value of Fairchem Organics Ltd is 232.
What is the Dividend Yield of Fairchem Organics Ltd?
The Dividend Yield of Fairchem Organics Ltd is 0.97 %.
What is the ROCE of Fairchem Organics Ltd?
The ROCE of Fairchem Organics Ltd is 10.2 %.
What is the ROE of Fairchem Organics Ltd?
The ROE of Fairchem Organics Ltd is 7.51 %.
What is the Face Value of Fairchem Organics Ltd?
The Face Value of Fairchem Organics Ltd is 10.0.